Caduet will also provide another big benefit for patients with health insurance: Because it is a single pill, patients will get both drugs for a single co-payment, making it inexpensive for them even after Norvasc becomes a cheap generic.
However, if nominal GDP grows at 4 percent per annum over the next 40 years, these payments would be closer to 1 percent of the GDP at the time of the payment, making it far easier to simply roll this debt over.